Drugs / HBS-201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07051252 | May → Oct 2025 | narcolepsy | Harmony Biosciences Management, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HBS-201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07051252 ↗ |
| Route | Oral | “Participants will take HBS-201 orally once daily in the morning upon wakening” NCT07051252 ↗ |